Janus Henderson Investors US’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Janus Henderson Investors US’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-249,995	Closed	-$14.8M	–	1224
2015 Q2	$14.8M	Sell	249,995 -145,494	-37%	-$10.3M	0.01%	650
2015 Q1	$42.3M	Buy	395,489 +33,666	+9%	+$3.21M	0.03%	489
2014 Q4	$34M	Buy	361,823 +3,310	+0.9%	+$316K	0.03%	518
2014 Q3	$27.5M	Buy	358,513 +272,066	+315%	+$21.4M	0.03%	530
2014 Q2	$7.76M	Buy	86,447 +40,767	+89%	+$2.5M	0.01%	725
2014 Q1	$2.44M	Buy	+45,680	New	+$1.51M	﹤0.01%	851

Other funds holding PTX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Janus Henderson Investors US's PTX Position: Q3 2015 in Review

Janus Henderson Investors US sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2015, closing a stake of 249,995 shares — an estimated $14.8M sold.

Janus Henderson Investors US first reported a position in PTX in Q1 2014 and held it in 6 quarters. The position peaked at $42.3M in Q1 2015. 104 funds tracked by Wall St. Rank hold PTX as of Q3 2015.

Janus Henderson Investors US reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2015 after selling out during the quarter.
Janus Henderson Investors US sold 249,995 Pernix Therapeutics Holdings, Inc. shares in Q3 2015, an estimated $14.8M.
Janus Henderson Investors US first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2014 and held it in 6 quarters.
Janus Henderson Investors US's Pernix Therapeutics Holdings, Inc. position peaked at $42.3M in Q1 2015.
104 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2015.

Based on Janus Henderson Investors US's 13F filing for Q3 2015, filed 17 Nov 2015.